Author:
Anekoson Joshua Istifanus,Bobai Mathew,Sokfa Woje Clement
Abstract
Infections caused by micro-organisms affect the health of people and animals, causing morbidity and mortality, with Asia and Africa as the epicenters. Some of the infectious diseases are emerging and re-emerging in nature. Examples include viral hepatitis, Lassa fever, Ebola, yellow fever, tuberculosis, covid-19, measles, and malaria, among others. Antimicrobials have been playing an important role in the treatment of infections by these microbes. However, there has been a development of resistance to these antimicrobials as a result of many drivers. This write-up used secondary data to explore the management of antimicrobial resistance (AMR) beyond the hospital antimicrobial resistance steward using the one health concept. The findings showed AMR to be a transboundary, multifaceted ecosystem problem affecting both the developed and developing countries. It is also one of the top ten global public health threats facing mankind. Globally, AMR will cost over US$100 trillion in output loss by 2050, about 700,000 deaths a year, and 4,150,000 deaths in Africa by 2050. About 2.4 million people could die in high-income countries between 2015 and 2050 without a sustained effort to contain AMR. The drivers of AMR are beyond the hospital and hospital AMR stewardship. Therefore, the need for one health concept to manage it.
Reference72 articles.
1. Gerald LM, John EB, Raphael D, Mandell D. Bennett Principle and Practice of Infectious Diseases. 7th Edition. Philadelphia, USA: Churchill Living Stone, Elsevier Limited. 2010
2. Bornard B, Delia R, John M. Africa’s Growing Risk of Diseases that Spread from Animals to People, 2020. IFFRI blogi - issue. Available at: https//www.iffri.org/blogi/africas-growing-risk-disease-spread-animals-people [Accessed on 26 January, 2022]
3. Fenollar F, Mediannikov O. Emerging Infectious Diseases in Africa in the 21st century. Philadelphia, USA: Elsevier Ltd. 2018
4. WHO. Antimicrobial Resistance. 2021. Available at https://www.who.int/news.room/fact.sheet/details/antimicrobialresistance [Accessed 20th January, 2022]
5. Carey EM, Steele DA. The severe Typhoid fever in Africa program highlights the need for broad deployment of typhoid conjugate vaccine. Clinical Infections Diseases. 2019;69(6):S413-S416
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献